PCR‐Free Innovative Strategies for SARS‐CoV‐2 Detection

Abstract

AbstractThe pandemic outbreak caused by SARS‐CoV‐2 coronavirus brought a crucial issue in public health causing up to now more than 600 million infected people and 6.5 million deaths. Conventional diagnostic methods are based on quantitative reverse transcription polymerase chain reaction (RT‐qPCR assay) and immuno‐detection (ELISA assay). However, despite these techniques have the advantages of being standardized and consolidated, they keep some main limitations in terms of accuracy (immunoassays), time/cost consumption of analysis, the need for qualified personnel, and lab constrain (molecular assays). There is crucial the need to develop new diagnostic approaches for accurate, fast and portable viral detection and quantification. Among these, PCR‐free biosensors represent the most appealing solution since they can allow molecular detection without the complexity of the PCR. This will enable the possibility to be integrated in portable and low‐cost systems for massive and decentralized screening of SARS‐CoV‐2 in a point‐of‐care (PoC) format, pointing to achieve a performant identification and control of infection. In this review, the most recent approaches for the SARS‐CoV‐2 PCR‐free detection are reported, describing both the instrumental and methodological features, and highlighting their suitability for a PoC application.